ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 153353 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 153353; 2) Community: the network communities that were significantly associated with the response to NSC 153353; 3) Molecule: the relationships between components within communities and NSC 153353; 4) MDR: the compounds that were significantly associated with the NSC 153353.

NSC Compound Enrichment Correlation
NSC 685503 Propanedinitrile, [5-amino-3,6-dicyano-1,2,4-trihydro-11b-methyl- [1]benzopyrano[2,3,4-de][1,6]naphthyridin-2-ylidene- 0.00311751113090895 0.34412722
NSC 692736 Null 0.00311751113090895 0.012476303
NSC 751623 Null 0.00311751113090895 0.024112099
NSC 271674 Carboxyphthalatoplatinum 0.00385572727186 0.24924041
NSC 625497 Antimony, dibromo(4-thiomorpholinecarbodithioato-S,S')-, (T-4)- 0.00385572727186 0.0036844218
NSC 683564 2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, methyl ester, (Z,E)- 0.00385572727186 -0.10715764
NSC 101003 Null 0.00385572727186009 0.24148007
NSC 268242 N,N-Dibenzyldaunorubicin 0.00396220821750022 0.34611822
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.00396220821750022 0.27262132
NSC 382034 2,4-Pyrimidinediamine, 6-ethyl-5-[4-(methylamino)- 3-nitrophenyl]- 0.00396220821750022 0.53722049
Total:92  Current:14    [First] [Prev] [Next] [Last]